The University of Texas MD Anderson Cancer Center has purchased two Elekta Versa HD linear accelerators. The radiation therapy system, which recently received 510(k) clearance from the U.S. Food and Drug Administration, features the versatility to deliver high-volume conventional techniques, in addition to the advanced linear-accelerator treatments that require the greatest targeting precision. MD Anderson predicts it will be ready to treat patients on the systems by January 2014.
Versa HD is equipped with the Agility multileaf collimator for high-speed, high-precision beam shaping to support extremely accurate tumor targeting and improved healthy tissue preservation. With previous beam shaping technologies, high-definition (HD) beam shaping was limited to small targets. Versa HD with Agility now enables high-definition beam shaping over a significantly larger treatment field, expanding advanced treatments to a broader spectrum of tumors.